Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Polpharma

02 7Sanofi

03 2Advanz Pharma

04 10Amgen Inc

05 2Apotex Inc

06 2BIOSIMILAR COLLABORATIONS IRELAND LIMITED

07 44Bayer AG

08 1Biocon Biologics

09 4Biosimilar Collaborations Ireland Limited

10 7Celltrion

11 7Formycon

12 2Regeneron Pharmaceuticals

13 4Samsung Bioepis

14 7Sandoz B2B

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEuropean CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Regulatory Info : Authorized

Registration Country : Spain

Aflibercept

Brand Name : Eiyzey

Dosage Form : Injectable Solution In Vial

Dosage Strength : 40MG

Packaging :

Approval Date : 28-08-2025

Application Number : 1251963002

Regulatory Info : Authorized

Registration Country : Spain

Polpharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

ZIV-AFLIBERCEPT

Brand Name : ZALTRAP

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number : 125418

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEuropean CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Regulatory Info : Authorized

Registration Country : Spain

Aflibercept

Brand Name : Eiyzey

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 40MG

Packaging :

Approval Date : 28-08-2025

Application Number : 1251963001

Regulatory Info : Authorized

Registration Country : Spain

Polpharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Aflibercept

Brand Name : Zaltrap

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date : 2013-02-01

Application Number : 20111126000035

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Aflibercept

Brand Name : Zaltrap

Dosage Form : Concentrate For Solution For Perfusion

Dosage Strength : 100mg/4ml

Packaging :

Approval Date : 2013-03-20

Application Number : 62676

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Aflibercept

Brand Name : Zaltrap

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 200mg/8ml

Packaging :

Approval Date : 2013-03-20

Application Number : 62676

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Authorized

Registration Country : Spain

Aflibercept

Brand Name : Zaltrap

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 22-02-2013

Application Number : 112814002

Regulatory Info : Authorized

Registration Country : Spain

Sanofi Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Authorized

Registration Country : Spain

Aflibercept

Brand Name : Zaltrap

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 22-02-2013

Application Number : 112814001

Regulatory Info : Authorized

Registration Country : Spain

Sanofi Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Authorized

Registration Country : Spain

Aflibercept

Brand Name : Zaltrap

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 22-02-2013

Application Number : 112814003

Regulatory Info : Authorized

Registration Country : Spain

Sanofi Company Banner

10

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

AFLIBERCEPT-AYYH

Brand Name : PAVBLU

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2 mg (0.05 mL of 40 mg/mL)

Packaging :

Approval Date :

Application Number : 761298

Regulatory Info :

Registration Country : USA

blank

11

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

AFLIBERCEPT-JBVF

Brand Name : YESAFILI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG(0.05ML,40MG/ML)

Packaging :

Approval Date :

Application Number : 761274

Regulatory Info :

Registration Country : USA

blank

12

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

AFLIBERCEPT-BOAV

Brand Name : EYDENZELT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG(0.05ML;40MG/ML)

Packaging :

Approval Date :

Application Number : 761377

Regulatory Info :

Registration Country : USA

blank

13

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

AFLIBERCEPT-MRBB

Brand Name : AHZANTIVE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG(0.05ML OF 40MG/ML)

Packaging :

Approval Date :

Application Number : 761378

Regulatory Info :

Registration Country : USA

blank

14

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Aflibercept

Brand Name : Ahzantive

Dosage Form : Injectable Solution

Dosage Strength : 40mg/ml

Packaging :

Approval Date : 2025-01-13

Application Number : 20240426000091

Regulatory Info : Approved

Registration Country : Sweden

blank

15

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

AFLIBERCEPT

Brand Name : EYLEA

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 40MG/ML

Packaging :

Approval Date :

Application Number : 125387

Regulatory Info :

Registration Country : USA

blank

16

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

AFLIBERCEPT

Brand Name : EYLEA HD

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 8MG(0.07ML;114.3MG/ML)

Packaging :

Approval Date :

Application Number : 761355

Regulatory Info :

Registration Country : USA

blank

17

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

AFLIBERCEPT-YSZY

Brand Name : OPUVIZ

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG(0.05ML,40MG/ML)

Packaging :

Approval Date :

Application Number : 761350

Regulatory Info :

Registration Country : USA

blank

18

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

AFLIBERCEPT-ABZV

Brand Name : ENZEEVU

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG(0.05ML of 40MG/ML)

Packaging :

Approval Date :

Application Number : 761382

Regulatory Info :

Registration Country : USA

blank

19

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Aflibercept

Brand Name : Afqlir

Dosage Form : Injectable Solution

Dosage Strength : 40mg/ml

Packaging :

Approval Date : 2024-11-13

Application Number : 20230823000046

Regulatory Info : Approved

Registration Country : Sweden

blank

20

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Aflibercept

Brand Name : Afqlir

Dosage Form : Solution For Injection

Dosage Strength : 40mg/ml

Packaging :

Approval Date : 2024-11-13

Application Number : 20230823000039

Regulatory Info : Approved

Registration Country : Sweden

blank